We are supporting numerous myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDS) trials.
In MPN, we are looking to see if a drug that is already used in breast cancer, will work for people who have MPN who have certain gene changes commonly found in this type of blood cancer. We also want to improve the outlook of people with MPN who have relapsed after receiving chemotherapy. Another trial is testing a new combination of drugs.
Our MDS trials want to improve the outlook of people who are unable to have high-intensity treatment, or relapse after a stem cell transplant.